Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. by Ayana Ablayeva (22103708)

Subjects:

Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and age-specific mortality to incidence ratios of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Regional and temporal burden of liver cancer in Kazakhstan (2014–2023). by Ayana Ablayeva (22103708)

Subjects:

A) CaCO₃ content versus number of treatments; B) UCS versus calcium carbonate content; C) permeability coefficient versus calcium carbonate content. by Jin Zhu (164147)

Subjects: “…permeability coefficients decreased…”

Between the PCSO-524 group and the placebo group unpaired comparisons of the change between visits of quality of life and respiratory variables scores. by Nattapon Riengvirodkij (11268720)

Subjects:

A flow diagram outlining the number of dogs in each group during the study (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70). by Nattapon Riengvirodkij (11268720)

Subjects:

Distribution of quality of life and respiratory variables scores of all 3 visits (visit = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group... by Nattapon Riengvirodkij (11268720)

Subjects:

The baseline characteristics of classifications and body condition score of the 2 groups (frequencies) at entry (visit 1, day 0). by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient of all 17 dogs. by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient in the PCSO-524 and placebo groups. by Nattapon Riengvirodkij (11268720)

Subjects:

Experimental groups. by Nida Saleem (17194610)

Subjects:

Estimated marginal mean (± SE) age group differences in the relative frequency of releases per minute, performed by professional soccer players on a match day for each position. by Emily Escreet (20552634)

Subjects: “…tailed statistical significance…”

TA–APTES Coating Facilitated Secondary Reactions for Synthesis of Multifunctional Porous Melamine Sponge and Application in Wastewater Treatment by Teng Chen (573322)

Subjects:

TA–APTES Coating Facilitated Secondary Reactions for Synthesis of Multifunctional Porous Melamine Sponge and Application in Wastewater Treatment by Teng Chen (573322)

Subjects:

TA–APTES Coating Facilitated Secondary Reactions for Synthesis of Multifunctional Porous Melamine Sponge and Application in Wastewater Treatment by Teng Chen (573322)

Subjects:

TA–APTES Coating Facilitated Secondary Reactions for Synthesis of Multifunctional Porous Melamine Sponge and Application in Wastewater Treatment by Teng Chen (573322)

Subjects: